BLMK ICB Direct Oral Anticoagulant (DOAC) Medication Review Service

Description

The Direct Oral Anticoagulant (DOAC) medication review service will assist Bedfordshire, Luton and Milton Keynes (BLMK) GP practices to deliver a high quality and safe DOAC review and change programme. Lot 1: The Direct Oral Anticoagulant (DOAC) medication review service will be delivered by provider employed non-medical prescribing pharmacist with clinical expertise in DOAC prescribing and experience of undertaken similar DOAC review and change programmes. Identifying, reviewing and where appropriate and with patients consent initiating/prescribing a cost-effective DOAC for the patient. <br/><br/>The contact has been awarded following direct award process A with a maximum contract value £165,000 based on £550 per clinical day (7.5hrs) and the contract value is activity related. The contract is for a period of 4 months from 1st September 2025 to 31st December 2025 with an option to extend for a period of up to 3months i.e. 31st March 2026, if required within the specified financial envelope.